STxB-E75

N/A

Report date: 2025/03/20 15:15:22

Base Information

Drug NameSTxB-E75

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapyVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccine +[6]

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryFrance

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesImmuno Targets SAS

China Registration ClassN/A

Develop Information

Active CompaniesImmuno Targets SAS

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A